BSIM2's mission is to boost the discovery and optimization of new drug candidates, led by computational methodologies and workflows, with a focus is on neurodegenerative amyloid diseases.
Company (Alive / Active)
Phone: +351 231 410 892
Instituto Pedro Nunes
R. Pedro Nunes, Edifício C
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)